Accessibility Menu
LeMaitre Vascular Stock Quote

LeMaitre Vascular (NASDAQ: LMAT)

$90.10
(0.4%)
+0.34
Price as of October 22, 2025, 4:00 p.m. ET

KEY DATA POINTS

Current Price
$90.1
Daily Change
(0.4%) +$0.34
Day's Range
$89.89 - $91.18
Previous Close
$90.1
Open
$89.98
Beta
0.81
Volume
89,927
Average Volume
167,294
Market Cap
2B
Market Cap / Employee
$90.10M
52wk Range
$71.42 - $109.58
Revenue
-
Gross Margin
0.67%
Dividend Yield
0.84%
EPS
$2.06
CAPs Rating
-
Industry
Healthcare Equipment and Supplies

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

LeMaitre Vascular Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
LMAT+4.12%+187.67%+23.53%+1,623%
S&P+14.5%+93.32%+14.09%+390%

LeMaitre Vascular Company Info

LeMaitre Vascular, Inc. engages in the provision of medical devices and human tissue cryopreservation services. The company focuses on the design, marketing, sales, service, and technical support of medical devices and implants for the treatment of peripheral vascular disease. Its products include balloon catheters, carotid shunts, biologic patches, radiopaque marking tape, anastomotic clips, remote endarterectomy devices, laparoscopic cholecystectomy devices, vascular grafts, and powered phlebectomy. The company was founded by George D. LeMaitre on November 28, 1983 and is headquartered in Burlington, MA.

News & Analysis

Financial Health

General

Q2 2025YOY Change
Revenue$64.23M15.0%
Gross Profit$43.54M17.7%
Gross Margin67.78%1.5%
Market Cap$1.88B1.6%
Market Cap / Employee$2.83M0.0%
Employees6645.4%
Net Income$13.78M16.5%
EBITDA$18.79M12.1%

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

Q2 2025YOY Change
Net Cash$27.18M22.0%
Accounts Receivable$36.54M18.5%
Inventory57.51.4%

Liabilities

Q2 2025YOY Change
Long Term Debt$183.06M1057.3%
Short Term Debt$2.83M9.2%

Ratios

Q2 2025YOY Change
Return On Assets10.02%-0.9%
Return On Invested Capital8.98%-0.5%

Cash Flow

Q2 2025YOY Change
Free Cash Flow$18.95M144.6%
Operating Free Cash Flow$20.29M110.8%

Valuation

MetricQ3 2024Q4 2024Q1 2025Q2 2025YoY Change
Price to Earnings50.9547.6242.4340.34-18.18%
Price to Book6.316.265.615.40-9.82%
Price to Sales9.969.608.498.10-10.90%
Price to Tangible Book Value9.179.098.037.59-16.85%
Price to Free Cash Flow TTM108.2492.6274.4352.68-48.52%
Enterprise Value to EBITDA129.43130.18118.8694.07-11.16%
Free Cash Flow Yield0.9%1.1%1.3%1.9%94.26%
Return on Equity13.3%13.9%13.8%13.8%10.59%
Total Debt$18.33M$185.69M$185.36M$185.89M909.77%

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.